ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

Browse by Author

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 10.

Journal Article

Nimbalkar, VP and Kruthika, BS and Sravya, P and Rao, S and Sugur, HS and Verma, BK and Chickabasaviah, YT and Arivazhagan, A and Kondaiah, P and Santosh, V (2021) Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence. In: Journal of Neuro-Oncology, 152 (1). pp. 55-65.

Arora, A and Patil, V and Kundu, P and Kondaiah, P and Hegde, AS and Arivazhagan, A and Santosh, V and Pal, D and Somasundaram, K (2019) Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma. In: Scientific Reports, 9 (1). p. 2749.

Kruthika, BS and Sugur, H and Nandaki, K and Arimappamagan, A and Paturu, K and Santosh, V (2019) Expression pattern and prognostic significance of myosin light chain 9 (MYL9): A novel biomarker in glioblastoma. In: Journal of Clinical Pathology, 72 (10). pp. 677-681.

Sravya, P and Nimbalkar, V P and Kanuri, N N and Rao, S and Arivazhagan, A and Somanna, S and Kondaiah, P and Santosh, V (2019) MITOCHONDRIAL DNA COPY NUMBER IN NEW ONSET AND RECURRENT GLIOBLASTOMA AND ITS EFFECT ON RADIATION RESISTANCE AND PATIENT SURVIVAL. In: NEURO-ONCOLOGY, 21 (3). p. 90.

Arora, A and Patil, V and Kundu, P and Kondaiah, P and Hegde, AS and Arivazhagan, A and Santosh, V and Pal, D and Somasundaram, K (2019) Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma. In: Scientific Reports, 9 (1).

Visvanathan, A and Patil, V and Arora, A and Hegde, A S and Arivazhagan, A and Santosh, V and Somasundaram, K (2018) Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance. In: ONCOGENE, 37 (4). pp. 522-533.

Mondal, B and Patil, V and Shwetha, S D and Sravani, K and Hegde, A S and Arivazhagan, A and Santosh, V and Kanduri, M and Somasundaram, K (2017) Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration. In: ONCOGENE, 36 (1). pp. 71-83.

Arivazhagan, A and Kumar, Durairaj Mohan and Sagar, Vinay and Patric, Irene Rosita Pia and Sridevi, S and Thota, Balaram and Srividya, Mallavarapu R and Prasanna, K and Thennarasu, K and Mondal, Neelima and Hegde, AS and Chandramouli, BA and Santosh, V and Rao, MRS and Kondaiah, P and Somasundaram, K (2012) Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor. In: JOURNAL OF NEURO-ONCOLOGY, 107 (2). pp. 289-297.

Editorials/Short Communications

Santosh, V and Shastry, AH and Thota, B and Arivazhagan, A and Thennarasu, K and Kumar, Praveen VR and Kondaiah, P (2014) Role of IGFBP family members and their downstream molecules in influencing glioblastoma pathogenesis and patient prognosis. In: BRAIN PATHOLOGY, 24 (1, SI).

Shastry, AH and Thota, B and Durgad, S and Thennarasu, K and Arivazhagan, A and Somanna, S and Kondaiah, P and Santosh, V (2014) The influence of p53 expression status on the association of STAT1 and MMP-9 with survival in glioblastoma: from molecular biology towards personalized medicine. In: BRAIN PATHOLOGY, 24 (1, SI).

This list was generated on Fri Mar 29 02:09:49 2024 IST.